vs
Natural Grocers by Vitamin Cottage, Inc.（NGVC）与PHIBRO ANIMAL HEALTH CORP（PAHC）财务数据对比。点击上方公司名可切换其他公司
PHIBRO ANIMAL HEALTH CORP的季度营收约是Natural Grocers by Vitamin Cottage, Inc.的1.1倍（$373.9M vs $335.6M），PHIBRO ANIMAL HEALTH CORP净利率更高（7.3% vs 3.4%，领先4.0%），PHIBRO ANIMAL HEALTH CORP同比增速更快（20.9% vs 1.6%），Natural Grocers by Vitamin Cottage, Inc.自由现金流更多（$11.6M vs $8.3M），过去两年PHIBRO ANIMAL HEALTH CORP的营收复合增速更高（19.2% vs 4.4%）
Natural Grocers by Vitamin Cottage, Inc.是美国本土的特色零售连锁企业，主营认证有机食品、膳食补充剂、天然个护及环保家居类产品，面向健康意识较强的消费群体，门店覆盖美国多州，执行严格品控标准，拒绝售卖含人工添加剂的商品。
菲宝罗动物保健公司是一家美国动物健康与矿物质营养企业，主营产品涵盖抗菌药、抗球虫药、驱虫药，以及畜禽营养补充剂、疫苗等。公司下设矿物质营养、功能材料、动物健康三大业务板块，收入主要来源于上述板块，业务遍及美国、拉美、加拿大、欧洲、中东、非洲及亚太地区。
NGVC vs PAHC — 直观对比
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $335.6M | $373.9M |
| 净利润 | $11.3M | $27.5M |
| 毛利率 | 29.5% | 35.5% |
| 营业利润率 | 4.4% | 13.5% |
| 净利率 | 3.4% | 7.3% |
| 营收同比 | 1.6% | 20.9% |
| 净利润同比 | 14.0% | 762.1% |
| 每股收益（稀释后） | $0.49 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $335.6M | $373.9M | ||
| Q3 25 | $336.1M | $363.9M | ||
| Q2 25 | $328.7M | $378.7M | ||
| Q1 25 | $335.8M | $347.8M | ||
| Q4 24 | $330.2M | $309.3M | ||
| Q3 24 | $322.7M | $260.4M | ||
| Q2 24 | $309.1M | $273.2M | ||
| Q1 24 | $308.1M | $263.2M |
| Q4 25 | $11.3M | $27.5M | ||
| Q3 25 | $11.8M | $26.5M | ||
| Q2 25 | $11.6M | $17.2M | ||
| Q1 25 | $13.1M | $20.9M | ||
| Q4 24 | $9.9M | $3.2M | ||
| Q3 24 | $9.0M | $7.0M | ||
| Q2 24 | $9.2M | $752.0K | ||
| Q1 24 | $8.0M | $8.4M |
| Q4 25 | 29.5% | 35.5% | ||
| Q3 25 | 29.5% | 32.9% | ||
| Q2 25 | 29.9% | 29.0% | ||
| Q1 25 | 30.3% | 30.1% | ||
| Q4 24 | 29.9% | 32.9% | ||
| Q3 24 | 29.6% | 32.1% | ||
| Q2 24 | 29.2% | 31.9% | ||
| Q1 24 | 29.3% | 30.2% |
| Q4 25 | 4.4% | 13.5% | ||
| Q3 25 | 4.6% | 14.1% | ||
| Q2 25 | 4.7% | 8.9% | ||
| Q1 25 | 5.2% | 9.6% | ||
| Q4 24 | 4.0% | 8.3% | ||
| Q3 24 | 3.7% | 6.8% | ||
| Q2 24 | 4.2% | 6.7% | ||
| Q1 24 | 3.7% | 7.6% |
| Q4 25 | 3.4% | 7.3% | ||
| Q3 25 | 3.5% | 7.3% | ||
| Q2 25 | 3.5% | 4.5% | ||
| Q1 25 | 3.9% | 6.0% | ||
| Q4 24 | 3.0% | 1.0% | ||
| Q3 24 | 2.8% | 2.7% | ||
| Q2 24 | 3.0% | 0.3% | ||
| Q1 24 | 2.6% | 3.2% |
| Q4 25 | $0.49 | $0.67 | ||
| Q3 25 | $0.51 | $0.65 | ||
| Q2 25 | $0.50 | $0.43 | ||
| Q1 25 | $0.56 | $0.51 | ||
| Q4 24 | $0.43 | $0.08 | ||
| Q3 24 | $0.38 | $0.17 | ||
| Q2 24 | $0.40 | $0.02 | ||
| Q1 24 | $0.35 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.2M | $74.5M |
| 总债务越低越好 | — | $624.2M |
| 股东权益账面价值 | $220.0M | $332.4M |
| 总资产 | $668.6M | $1.4B |
| 负债/权益比越低杠杆越低 | — | 1.88× |
8季度趋势，按日历期对齐
| Q4 25 | $23.2M | $74.5M | ||
| Q3 25 | $17.1M | $85.3M | ||
| Q2 25 | $13.2M | $77.0M | ||
| Q1 25 | $21.2M | $70.4M | ||
| Q4 24 | $6.3M | $67.1M | ||
| Q3 24 | $8.9M | $89.8M | ||
| Q2 24 | $13.9M | $114.6M | ||
| Q1 24 | $11.0M | $98.7M |
| Q4 25 | — | $624.2M | ||
| Q3 25 | — | $628.0M | ||
| Q2 25 | — | $631.7M | ||
| Q1 25 | — | $635.4M | ||
| Q4 24 | — | $639.1M | ||
| Q3 24 | — | $295.2M | ||
| Q2 24 | — | $312.1M | ||
| Q1 24 | — | — |
| Q4 25 | $220.0M | $332.4M | ||
| Q3 25 | $212.4M | $311.7M | ||
| Q2 25 | $202.5M | $285.7M | ||
| Q1 25 | $193.0M | $266.0M | ||
| Q4 24 | $181.9M | $246.8M | ||
| Q3 24 | $174.3M | $258.5M | ||
| Q2 24 | $167.8M | $256.6M | ||
| Q1 24 | $160.0M | $270.1M |
| Q4 25 | $668.6M | $1.4B | ||
| Q3 25 | $670.5M | $1.4B | ||
| Q2 25 | $659.0M | $1.4B | ||
| Q1 25 | $664.6M | $1.3B | ||
| Q4 24 | $648.9M | $1.3B | ||
| Q3 24 | $655.5M | $966.3M | ||
| Q2 24 | $654.4M | $982.2M | ||
| Q1 24 | $656.6M | $979.0M |
| Q4 25 | — | 1.88× | ||
| Q3 25 | — | 2.01× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 2.39× | ||
| Q4 24 | — | 2.59× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.22× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.1M | $19.4M |
| 自由现金流经营现金流 - 资本支出 | $11.6M | $8.3M |
| 自由现金流率自由现金流/营收 | 3.4% | 2.2% |
| 资本支出强度资本支出/营收 | 2.9% | 3.0% |
| 现金转化率经营现金流/净利润 | 1.86× | 0.70× |
| 过去12个月自由现金流最近4个季度 | $42.6M | $47.3M |
8季度趋势，按日历期对齐
| Q4 25 | $21.1M | $19.4M | ||
| Q3 25 | $15.6M | $9.3M | ||
| Q2 25 | $2.9M | $21.3M | ||
| Q1 25 | $34.1M | $43.2M | ||
| Q4 24 | $2.7M | $3.1M | ||
| Q3 24 | $24.5M | $12.6M | ||
| Q2 24 | $12.4M | $28.4M | ||
| Q1 24 | $20.2M | $11.4M |
| Q4 25 | $11.6M | $8.3M | ||
| Q3 25 | $7.5M | $-4.5M | ||
| Q2 25 | $-4.2M | $8.1M | ||
| Q1 25 | $27.6M | $35.4M | ||
| Q4 24 | $-6.9M | $-4.7M | ||
| Q3 24 | $18.0M | $3.0M | ||
| Q2 24 | $3.6M | $15.4M | ||
| Q1 24 | $9.8M | $1.7M |
| Q4 25 | 3.4% | 2.2% | ||
| Q3 25 | 2.2% | -1.2% | ||
| Q2 25 | -1.3% | 2.1% | ||
| Q1 25 | 8.2% | 10.2% | ||
| Q4 24 | -2.1% | -1.5% | ||
| Q3 24 | 5.6% | 1.2% | ||
| Q2 24 | 1.2% | 5.6% | ||
| Q1 24 | 3.2% | 0.6% |
| Q4 25 | 2.9% | 3.0% | ||
| Q3 25 | 2.4% | 3.8% | ||
| Q2 25 | 2.2% | 3.5% | ||
| Q1 25 | 1.9% | 2.2% | ||
| Q4 24 | 2.9% | 2.5% | ||
| Q3 24 | 2.0% | 3.7% | ||
| Q2 24 | 2.9% | 4.8% | ||
| Q1 24 | 3.4% | 3.7% |
| Q4 25 | 1.86× | 0.70× | ||
| Q3 25 | 1.32× | 0.35× | ||
| Q2 25 | 0.25× | 1.24× | ||
| Q1 25 | 2.60× | 2.07× | ||
| Q4 24 | 0.27× | 0.97× | ||
| Q3 24 | 2.72× | 1.81× | ||
| Q2 24 | 1.35× | 37.80× | ||
| Q1 24 | 2.54× | 1.36× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NGVC
| Grocery | $243.8M | 73% |
| Dietary Supplements | $60.7M | 18% |
| Manufactured Product Other | $31.0M | 9% |
PAHC
| Medicated Feed Additives And Others | $202.1M | 54% |
| Mineral Nutrition | $68.9M | 18% |
| Nutritional Specialties | $50.2M | 13% |
| Vaccines | $37.6M | 10% |
| Performance Products | $15.0M | 4% |
